Estimates Revisions Astellas Pharma Inc. Deutsche Boerse AG
Stocks
YPHA
US04623U1025
Pharmaceuticals
|
Market Closed -
Deutsche Boerse AG
02:01:50 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 12.10 EUR | +0.83% |
|
-1.63% | +9.01% |
| 08-17 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 4503 Stock
- YPHA Stock
- Consensus Astellas Pharma Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
